72 weeks treatment duration reduces relapse rate in hcv/hiv co-infected patients with end of treatment response (2010)
- Authors:
- Autor USP: BARONE, ANTONIO ALCI - FM
- Unidade: FM
- Subjects: HOSPEDEIRO IMUNOCOMPROMETIDO; INFECÇÕES POR HIV; GENÓTIPOS; RESUMOS (EVENTOS); HEPATITE C (VIROLOGIA); HEPATITE VIRAL HUMANA
- Language: Inglês
- Imprenta:
- Source:
- Título: Hepatology
- ISSN: 0270-9139
- Volume/Número/Paginação/Ano: v. 52, n. 4 (suppl), p. 785A, res. 963, 2010
-
ABNT
MELLO, Carlos E. Brandão et al. 72 weeks treatment duration reduces relapse rate in hcv/hiv co-infected patients with end of treatment response. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 jan. 2026. , 2010 -
APA
Mello, C. E. B., Cheinquer, H., Marins, E. G., & Barone, A. A. (2010). 72 weeks treatment duration reduces relapse rate in hcv/hiv co-infected patients with end of treatment response. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Mello CEB, Cheinquer H, Marins EG, Barone AA. 72 weeks treatment duration reduces relapse rate in hcv/hiv co-infected patients with end of treatment response. Hepatology. 2010 ; 52( 4 (suppl): 785A.[citado 2026 jan. 10 ] -
Vancouver
Mello CEB, Cheinquer H, Marins EG, Barone AA. 72 weeks treatment duration reduces relapse rate in hcv/hiv co-infected patients with end of treatment response. Hepatology. 2010 ; 52( 4 (suppl): 785A.[citado 2026 jan. 10 ] - Weigt-based combination therapy with peginterferon alfa 2b and ribavirin for naïve, relapser and non-responder patients with chronic hepatitis C
- Patients with chronic hepatitis C and normal transaminases
- Clinical classification of tetanus patients
- Hepatite C
- Therapeutic perspectives for hepatitis C
- Hepatite B
- The interleukin-10 - 1082 G/A promoter polymorphism and the outcome of HCV infection
- Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin [Carta]
- Sangue seguro [Editorial]: mito ou realidade?
- Sociedade paulista de infectologia realiza I consenso de manuseio e terapia da hepatite C [Entrevista]
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
